Jci_page_head_homepage_01 Jci_page_head_homepage_02
John A. Phillips III
Published in Volume 112, Issue 11
J Clin Invest. 2003; 112(11):1641–1643 doi:10.1172/JCI20441
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

In the pathogenesis of FNDI, normal and Cys67Ter AVP products interact to prevent AVP secretion. These products also accumulate within, damage, and cause loss of AVP secretory cells.